The FDA has approved a non-steroidal class of drugs for eczema suffers with very good initial trials. The drug is called Protopic(tacrolimus)generally about .1% for adults >03% children. The drug is specifically for eczema patients for whom the standard treatments have not worked or have been inadvisable due to potential risks.